Regen BioPharma Inc (RGBP)

[cvinvestor]

Sage. As long as CRL verifies the HemaX safety test results, i.e. they duplicate the results or better that RGBP had previously submitted, then the IND approval of HemaX by the FDA will put RGBP and all other pipeline products on the map.

Along with others on this board, I think that event will prove most significant and lasting in creating the volume, interest and price movement due to investment firm positions being taken in the company.

Until then, we can expect smaller fish in the aquarium along with sharp up and downs. Once we get first IND approval, current pricing should be a thing of the past.

When that will come people differ as to timeframe, but we all should feel better about CRL being part of the game and the potential future expansion of RGBP and the role CRL could play in moving new INDs through the process much quicker than RGBP has been able to do in the past.

Gotta get out of the gate first and things may spiral.